文献速递真菌感染

血清(1,3)-β-D-葡聚糖诊断新生儿侵袭性念珠菌病的系统评价与荟萃分析

Diagnostic accuracy of serum (1,3)-beta-d-glucan for neonatal invasive candidiasis: systematic review and meta-analysis.
PubMed 文献 · Clin Microbiol Infect · 2019-09-17

该系统评价与荟萃分析纳入8项研究共465例疑似新生儿侵袭性念珠菌病(NIC)患儿,评估血清BDG(Fungitell®法)的诊断准确性。在80 pg/mL阈值下汇总敏感度89%、特异度60%,对确诊NIC的敏感度达99%;120 pg/mL阈值下敏感度81%、特异度80%。作者认为BDG高敏感度有望用于排除NIC,但因可靠临床数据稀缺、病例定义异质性和准确性估计不稳定,尚不宜推荐常规使用。

要点

  • 80 pg/mL阈值下BDG汇总敏感度89%、特异度60%,排除确诊NIC敏感度99%。
  • 120 pg/mL阈值下BDG汇总敏感度81%、特异度80%。
  • 病例定义异质性大、准确性估计不稳定,暂不推荐常规使用。

核心结论

  • BDG因高敏感度似乎有希望用于排除新生儿侵袭性念珠菌病。
  • 因可靠临床数据稀缺、病例定义异质性和准确性估计不稳定,推荐其使用可能为时过早。

研究设计与样本

  • 系统评价与荟萃分析,检索Medline、Embase、Clinicaltrials.gov和Google Scholar(建库至2019年7月)。
  • 纳入8项研究共465例疑似NIC新生儿,评估血清BDG(Fungitell®法)诊断准确性。
  • 采用QUADAS-2评估偏倚风险与适用性,使用双变量荟萃分析在80和120 pg/mL预设阳性阈值下汇总诊断准确性。
  • 研究注册于PROSPERO(CRD42018089545)。

主要发现

  • 8项研究中仅2项总体偏倚风险低。
  • 各研究采用的参考标准存在实质性差异。
  • 80 pg/mL阈值下BDG汇总敏感度89%(95% CI: 80-94%)、特异度60%(53-66%)。
  • 80 pg/mL阈值下检测确诊NIC病例的汇总敏感度为99%(93-100%)。
  • 120 pg/mL阈值下BDG汇总敏感度81%(71-88%)、特异度80%(67-88%)。

关键数值与推荐

  • 预设BDG阳性阈值分别为80 pg/mL和120 pg/mL。
  • 参考标准需定义具有序贯NIC概率(如确诊、很可能、可能)的患者组,并包括真菌血培养。

临床怎么用

  • BDG高敏感度(80 pg/mL下对确诊NIC达99%)可用于排除NIC,但需结合临床背景。
  • 因数据稀缺和异质性,暂不推荐将BDG常规用于NIC诊断,应个体化解读结果。

局限性

  • 仅8项研究、465例患儿,可靠临床数据稀缺。
  • 各研究参考标准存在实质性差异,病例定义异质。
  • 仅2项研究总体偏倚风险低,准确性估计不稳定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Neonatal invasive candidiasis (NIC) is a leading cause of infection-related morbidity and mortality in preterm neonates. Several studies have shown that (1,3)-Beta-d-glucan (BDG) was accurate in detecting invasive fungal infection in adults, but studies in neonates are scarce. The aim was to obtain summary estimates of the accuracy of BDG detection in serum for the diagnosis of NIC. METHODS: We searched Medline, Embase, Clinicaltrials.gov, and Google Scholar (inception to July 2019). We checked the reference lists of included studies, clinical guidelines, and review articles. We included studies that assessed the accuracy of BDG against a reference standard that defined groups of patients with ordinal levels of NIC probability (e.g. proven, probable, possible) and included fungal blood culture. Participants were neonates suspected of having NIC. The intervention was BDG measurement in serum (Fungitell® assay). We assessed risk of bias and applicability using QUADAS-2. We used bivariate meta-analysis to produce summary estimates of diagnostic accuracy at prespecified positivity thresholds of 80 and 120 pg/mL. This study was registered with PROSPERO (CRD42018089545). RESULTS: We included eight studies (465 participants). Of these, two were judged at low overall risk of bias. There was substantial variability across studies in the reference standards used. At a positivity threshold of 80 pg/mL, summary estimates of sensitivity and specificity of BDG were 89% (95% CI: 80-94%) and 60% (53-66%), respectively; summary sensitivity for detecting proven cases of NIC was 99% (93-100%). At a positivity threshold of 120 pg/mL, summary estimates of sensitivity and specificity were 81% (71-88%) and 80% (67-88%), respectively. CONCLUSIONS: Because of high sensitivity, BDG seems promising to rule-out NIC. It might be too early to recommend its use because of the scarcity of reliable clinical data, heterogeneity in case definitions, and unstable accuracy estimates.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Cohen JF, Ouziel A, Matczak S, et al. Diagnostic accuracy of serum (1,3)-beta-d-glucan for neonatal invasive candidiasis: systematic review and meta-analysis. Clin Microbiol Infect. 2019. PMID: 31539634. doi:10.1016/j.cmi.2019.09.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。